Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Florida guideFlorida Bids and Bidding Guide
  • Before you submitBid Response: 3 Common Mistakes When Submitting an RFP
More chemical manufacturing bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Florida
  4. ›Chemical Manufacturing
  5. ›RO Membrane Scale Inhibitor (Antiscalant)

Awarded contract·City of Palm Bay·Florida

RO Membrane Scale Inhibitor (Antiscalant)

Won by King Lee Technologies +5 more$42kMultiple Award
Contract source

Awarded vendors

  • King Lee Technologies
  • American Water Chemicals, Inc.
  • Harcros Chemicals Inc.
  • Consolidated Water Solutions
  • Sterling Water Technologies Inc.
  • Univar Solutions USA Inc.

Description

The City of Palm Bay is requesting bids from qualified suppliers for RO Membrane Scale Inhibitor – Antiscalant. The contract requires the supplier to provide a product that conforms to ANSI/NSF Standard 60, latest for RO Membrane Scale Inhibitors. The unit price shall include costs for product, delivery, insurance, permits, testing, and other related fees. The following are key points about the contract: • The contract is for the supply of RO Membrane Scale Inhibitor – Antiscalant. • The product must conform to ANSI/NSF Standard 60, latest for RO Membrane Scale Inhibitors. • The unit price shall include costs for product, delivery, insurance, permits, testing, and other related fees. • The contract does not consider a change in dosage. • The bid submission date was February 11, 2020, at 5:00:00 PM EST.

Attached files

Key dates

Last updated

Details

Award type
Multiple Award
Procurement
Full and Open Competition
Industry
Chemical Manufacturing
NAICS
325998
Solicitation №
31-0-2020

Contract value

$41,850

Based on the bid prices provided, the estimated value of the contract can be calculated. The prices range from $36,450.00 to $47,250.00. Assuming an average price of $41,850.00, the estimated value of the contract would be around $41,850.00. However, this is just an estimate and the actual value of the contract may be different. Factors that may influence the likely contract value include the quantity of the product required, the delivery costs, and the testing and permit fees.

AI estimate from the award documents

Similar open opportunities

Matched by Bid Banana AI™

LA General Services·California

Top match · 62%

ANTISCALANT (PRETREAT PLUS 0100), MFR. KING LEE TECHNOLOGIES

Closes 11/5/2026Opened 10/30/2026

U.S. Department Of Energy·Ohio

58% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. Department Of Health And Human Services·Indiana

58% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. Department Of Energy·Ohio

56% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. National Institutes of Health·United States of America

56% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. Food and Drug Administration·United States of America

56% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Energy·New Mexico

56% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. Department Of Defense·Vermont

55% match

Rivastigmine 24HR Patches

Closes 9/14/2028Opened 9/30/2021

Texas Tx Comm On Environ Quality·Texas

55% match

Membrane Filters

Closes 11/4/2026Opened 10/20/2026

Ohio Department of Rehabilitation and Correction·Ohio

55% match

APEX RAMAN SPECTROMETER - DRC27 - CCI

Closes 11/9/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

55% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. Department Of Defense·New York

55% match

Clobetasol Propionate

Closes 8/28/2029Opened 11/21/2022

St. Tammany Parish Mosquito Abatement District·Louisiana

55% match

#1025 Larvicide and Insecticide Products

Closes 11/13/2026Opened 10/19/2026

U.S. Department Of Defense·United States of America

55% match

Olopatadine HCL 0.1% Ophthalmic Solution

Closes 2/15/2028Opened 6/3/2022

U.S. Food and Drug Administration·United States of America

55% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Rolling / TBD closeOpened 11/5/2024

U.S. Food and Drug Administration·United States of America

54% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Closes 4/1/2027Opened 7/11/2025

U.S. Department Of Health And Human Services·District of Columbia

54% match

Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening

Closes 11/10/2026Opened 10/21/2026

U.S. Department Of Defense·United States of America

54% match

GLAND,ACTUATOR

Closes 11/27/2026Opened 10/28/2026

U.S. Food and Drug Administration·United States of America

54% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

Arkansas Department of Finance and Administration·Arkansas

54% match

Residential Substance Abuse Treatment For State Prisoners Program (RSAT)

Rolling / TBD closeOpened 12/12/2024

U.S. Department Of Defense·United States of America

54% match

Morphine Sulfate Solution

Closes 12/21/2026Opened 9/21/2026

U.S. Department Of Health And Human Services·United States of America

54% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

54% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. Department Of Health And Human Services·Maryland

54% match

NCSS - Preventative Maintenance Service & Support

Closes 11/11/2026Opened 10/28/2026

U.S. Department Of Defense·Maryland

54% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026